Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia
Open Access
- 1 July 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (1) , 372-374
- https://doi.org/10.1182/blood.v96.1.372
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.European Journal of Haematology, 2009
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type ChemotherapyBlood, 1997
- Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesisAmerican Journal of Hematology, 1995